Trazodone can cause bladder problems in a small number of people, though these effects are uncommon compared to the drug’s more frequently reported side effects like drowsiness and dizziness. The two main bladder-related issues linked to trazodone are urinary retention, where you have difficulty emptying your bladder, and nocturnal enuresis, or bedwetting during sleep. Both are considered rare, but they are documented in pharmacovigilance databases and case reports, and they tend to catch people off guard because bladder effects are not prominently featured in the standard warnings most patients receive.
What the Adverse Event Data Actually Show
The clearest picture of trazodone’s bladder-related risks comes from large-scale adverse event databases rather than from clinical trials, because these effects are rare enough that they rarely show up in standard study sizes. A pharmacovigilance study using the FDA’s adverse event reporting system analyzed over 5,000 reports where trazodone was the primary suspected drug and identified 179 significant adverse event signals, some of which were not listed in the drug’s standard prescribing information.1Nature / Scientific Reports. A realworld pharmacovigilance study of trazodone based on the FDA adverse event reporting system While the study’s headline signals involved suicide, abnormal penile erection, insomnia, and cardiac and respiratory arrest, the database also contained urinary complaints that warranted further scrutiny.
A separate analysis using Japan’s adverse drug event report database looked specifically at urinary retention caused by psychotropic medications. Among trazodone users in that database, about 1.4% of cases involved urinary retention, and trazodone carried a reporting odds ratio of 2.70, meaning reports of urinary retention were roughly two and a half times more common than you would expect by chance.2PubMed Central. A Pharmacovigilance Study on Psychotropic Agent-Induced Urinary Retention Using the Japanese Adverse Drug Event Report Database That puts trazodone in the company of other antidepressants known to occasionally interfere with bladder function, though its signal was modest compared to some older tricyclic antidepressants.
These database numbers deserve context. Pharmacovigilance databases capture voluntary reports, so they tend to undercount milder events that patients never mention to their doctors. At the same time, a reporting odds ratio is not the same as absolute risk. What the data reliably tell us is that trazodone does occasionally interfere with normal bladder function, and that the association is real rather than coincidental.
Urinary Retention and Who Is Most Vulnerable
Urinary retention is the more concerning of the two bladder effects because it can escalate into a medical emergency if the bladder becomes dangerously full. The mechanism involves trazodone’s effects on the nervous system pathways that control the bladder’s detrusor muscle and the internal urethral sphincter. Trazodone blocks certain receptors, including alpha-adrenergic receptors, that play a role in coordinating the relaxation and contraction needed to urinate. When this coordination gets disrupted, the bladder may not empty properly.
People with pre-existing conditions that already compromise urinary function are at the greatest risk. A case report described a 60-year-old man with benign prostatic hyperplasia (an enlarged prostate) who developed acute urinary retention while taking trazodone along with buprenorphine/naloxone and lurasidone.3PubMed Central. An Additive Mix? Acute Urinary Retention in a Patient With Benign Prostatic Hyperplasia Treated With Suboxone, Lurasidone, and Trazodone The case highlights a crucial point: trazodone alone may not push someone into urinary retention, but when combined with other medications that also affect the voiding process, the additive effect can tip the balance. Opioids, antipsychotics, and antihistamines are all common co-prescribed drugs that share this property.
If you already struggle to start urination, notice a weak stream, or feel like your bladder never fully empties, adding trazodone to the mix is worth a conversation with your prescriber. This is especially relevant for older men with prostate enlargement, but it can happen in anyone whose urinary system is already working at a disadvantage. The risk rises further when multiple medications with anticholinergic or alpha-blocking properties are prescribed simultaneously.
Nocturnal Enuresis, the Less-Discussed Side Effect
The other bladder problem linked to trazodone is nocturnal enuresis, or involuntary urination during sleep. For adults who have never experienced bedwetting since childhood, waking up to a wet bed after starting a new medication can be alarming and deeply embarrassing. Trazodone has been associated with this side effect in case literature, and it is thought to result from the drug’s sedative properties combined with its effects on the neurochemical signals that normally keep the bladder quiescent during sleep.4ResearchGate. Trazodone-induced nocturnal enuresis
Trazodone is one of the most sedating antidepressants available, which is precisely why it is so widely prescribed as a sleep aid. But that deep sedation may blunt the brain’s ability to wake you up when the bladder signals it is full. In someone who already sleeps heavily, or who takes trazodone at a higher dose, the combination of a full bladder and a deeply suppressed arousal response can lead to involuntary voiding. Drinking fluids close to bedtime or taking trazodone along with other sedating substances like alcohol or benzodiazepines may increase this risk.
If you experience bedwetting after starting trazodone, the evidence suggests it resolves when the medication is stopped or the dose is reduced. It is worth noting that this side effect is considered rare in the general trazodone-using population, but “rare” provides little comfort if it happens to you. Telling your doctor is important even though the topic feels awkward, because the solution is usually straightforward.
The Paradox of Trazodone and Bedwetting in Children
Interestingly, trazodone has been studied as a potential treatment for childhood bedwetting, which seems to contradict the idea that it causes enuresis. A small study gave trazodone to nine school-age children with treatment-resistant nocturnal enuresis and found that one child improved markedly and more than half showed partial improvement.5German J Psychiatry. Efficacy of Trazodone in the Treatment of Nocturnal Enuresis in School Age Children The researchers suggested trazodone could be a promising approach for children who hadn’t responded to standard treatments.
This apparent contradiction makes more sense when you consider that childhood nocturnal enuresis and trazodone-induced enuresis in adults likely involve different mechanisms. In children, the problem is often a maturational delay in the brain-bladder signaling loop, and trazodone’s serotonergic effects may help strengthen those signals. In adults, the issue is more about sedation overwhelming an otherwise functional arousal system. The same drug can have opposite functional outcomes depending on what is going wrong in the first place. This is a good reminder that medication effects are not one-size-fits-all, and that a side effect in one population does not automatically apply to another.
The Priapism Connection and Broader Urological Effects
Any discussion of trazodone and the urinary tract would be incomplete without addressing priapism, a prolonged and painful erection unrelated to sexual arousal. While priapism is technically not a “bladder problem,” it is the most well-known urological side effect of trazodone, and it shares common ground with the bladder issues because both stem from trazodone’s alpha-adrenergic blocking activity.
A study tracking patients started on trazodone found that about 8% developed prolonged erections, but only two out of 18 affected patients had been warned about this risk before starting the drug.6Investigative and Clinical Urology. Pretreatment screening and counseling on prolonged erections for patients prescribed trazodone Only five of those 18 patients mentioned the problem to their doctors, primarily because of embarrassment or because they did not realize trazodone could be the cause. The FDA pharmacovigilance study similarly flagged abnormal penile erection as one of the most frequently reported adverse events linked to the drug.1Nature / Scientific Reports. A realworld pharmacovigilance study of trazodone based on the FDA adverse event reporting system
Priapism is a medical emergency that can cause permanent damage to erectile tissue if left untreated for more than a few hours. The reason it matters in a discussion about bladder problems is twofold. First, the same receptor-blocking mechanism that contributes to priapism is involved in urinary retention. Second, the pattern of underreporting seen with priapism almost certainly applies to bladder complaints as well. If patients are too embarrassed to mention prolonged erections to their doctors, they are probably even less likely to bring up difficulty urinating or, worse, bedwetting. The true prevalence of trazodone-related bladder problems is likely higher than what shows up in any database.
Why Bladder Effects Are Easy to Miss
Several factors conspire to make trazodone’s bladder side effects fly under the radar. The drug is most commonly prescribed off-label as a sleep aid at doses lower than those used for depression. At these lower doses, serious side effects of any kind are less frequent, which can create a perception that the drug is nearly side-effect-free apart from sedation. Prescribers and patients alike may not think of trazodone as a medication that affects the urinary tract.
Timing also plays a role. Because trazodone is taken at bedtime, the onset of urinary symptoms happens during sleep or in the middle of the night, making them easy to attribute to something else. An older man who starts having trouble urinating might blame his prostate. A woman who experiences an episode of nighttime incontinence might attribute it to a urinary tract infection, age, or fluid intake. Without a prompt to consider the medication as a cause, patients may go weeks or months without connecting the dots.
The demographics of trazodone use also complicate the picture. The FDA pharmacovigilance data show a higher proportion of female users reporting adverse events overall.1Nature / Scientific Reports. A realworld pharmacovigilance study of trazodone based on the FDA adverse event reporting system Meanwhile, urinary retention tends to be studied and discussed primarily in the context of older men with prostate problems. This creates a blind spot: women taking trazodone who develop subtle urinary difficulties may not be screened for medication-related causes because the clinician’s mental model of “drug-induced urinary retention” defaults to an older male patient.
What to Do if You Suspect a Problem
If you notice changes in your urinary habits after starting trazodone or after a dose increase, a few practical steps can help you and your doctor sort out what is going on:
- Track the timing: Note when symptoms started relative to when you began or increased the medication. A clear temporal association, where problems appeared within days or weeks of the change, makes a drug-related cause more plausible.
- Review your other medications: If you are taking other drugs with anticholinergic or alpha-blocking properties, the combination may be the culprit rather than trazodone alone. Antihistamines, opioids, some antipsychotics, and certain muscle relaxants all have similar effects on the bladder.
- Do not stop trazodone abruptly: Discontinuing any antidepressant without guidance can cause withdrawal symptoms. If you suspect a bladder side effect, bring it up with your prescriber rather than stopping on your own.
- Limit bedtime fluids: If nocturnal enuresis is the issue, reducing fluid intake in the two hours before taking trazodone may lessen the risk while you and your doctor decide on next steps.
In most cases, trazodone-related bladder effects resolve once the drug is discontinued or the dose is lowered. Your doctor may also consider switching to a different sleep aid or antidepressant that lacks significant alpha-blocking activity, which should eliminate the urinary side effects while still addressing the condition trazodone was prescribed for.
How Trazodone Compares to Other Antidepressants
Trazodone is not the only antidepressant that can affect the bladder, but it occupies a middle position in terms of risk. Older tricyclic antidepressants like amitriptyline and imipramine have stronger anticholinergic effects and are more frequently associated with urinary retention. The Japanese pharmacovigilance analysis found that antidepressants as a class carried a reporting odds ratio for urinary retention well above baseline, with some individual drugs showing much higher signals than trazodone’s 2.70.2PubMed Central. A Pharmacovigilance Study on Psychotropic Agent-Induced Urinary Retention Using the Japanese Adverse Drug Event Report Database Selective serotonin reuptake inhibitors (SSRIs) like sertraline and fluoxetine also occasionally cause urinary retention, though through a somewhat different mechanism.
What makes trazodone unusual is its specific combination of strong sedation, alpha-adrenergic blockade, and serotonergic activity, all of which independently touch the urinary system in different ways. That multifaceted pharmacology is part of why trazodone can cause both retention and enuresis, depending on the person and the circumstances. Most antidepressants tend to lean more heavily toward one or the other. Trazodone’s versatility as a drug, the same quality that makes it useful across depression, insomnia, and anxiety, also gives it a wider range of possible urological side effects.
For people who need a sleep aid and are concerned about bladder effects, discussing alternatives with a prescriber is reasonable. Melatonin receptor agonists and orexin receptor antagonists, both newer classes of sleep medications, do not share trazodone’s alpha-blocking mechanism and carry essentially no known urinary side effects. Whether they are appropriate depends on the underlying reason trazodone was prescribed, since these alternatives do not treat depression or anxiety.
When an Enlarged Prostate Is Already in the Picture
The case report of the 60-year-old man who developed acute urinary retention illustrates a scenario that primary care and psychiatric prescribers encounter regularly: a patient with both a mental health condition and an enlarged prostate.3PubMed Central. An Additive Mix? Acute Urinary Retention in a Patient With Benign Prostatic Hyperplasia Treated With Suboxone, Lurasidone, and Trazodone Benign prostatic hyperplasia affects roughly half of men by their sixties, so overlap with psychiatric medication use is extremely common.
In that case, the patient was taking three medications simultaneously, each of which could independently contribute to urinary retention. The compounding effect is the critical lesson: a man who tolerates each drug individually at modest doses may still develop retention when two or three are combined. If you have been diagnosed with prostate enlargement, keeping all of your prescribers informed about your full medication list is essential. Urologists and psychiatrists do not always share the same chart, and the interaction between their respective prescriptions can produce side effects neither anticipated alone.
Acute urinary retention, where you suddenly cannot urinate at all, requires emergency treatment with catheterization. If you find yourself completely unable to void and are taking trazodone or any combination of psychotropic medications, seek medical attention promptly rather than waiting to see if it resolves. The discomfort alone usually drives people to the emergency room, but the risk of bladder damage from overdistension makes speed important even if the discomfort seems tolerable.